Health Care Price Competition

38 Results

number of items to display at a time

Commentary

Apr 23, 2025

Redesigning Health Care Plans to Lower Costs

Employers and employees can use their health insurance benefit designs to make health care more affordable, and without the need for further taxpayer subsidies, by designing tiered networks of providers who are responsible for meeting specific total cost of care benchmarks.
Research

Dec 10, 2024

Prices Paid to Hospitals by Private Health Plans: Findings from Round 5.1 of an Employer-Led Transparency Initiative

The lack of transparency of prices in the U.S. health care market limits employers' ability to knowledgeably develop or implement benefit design decisions. This report presents a metric that can be used to compare hospital prices.
Nov 13, 2024

Benefits and Affordability

RAND Health Care research addressing health care benefits and affordability.
Press

May 13, 2024

Private Health Plans During 2022 Paid Hospitals 254 Percent of What Medicare Would Pay

Prices paid to hospitals during 2022 by employers and private insurers for both inpatient and outpatient services averaged 254 percent of what Medicare would have paid, with wide variation in prices among states.
Press

Feb 1, 2024

Prescription Drug Prices in the U.S. Are 2.78 Times Those in Other Countries

Prescription drug prices in the United States are significantly higher than in other nations, with prices in the United States averaging 2.78 times those seen in 33 other nations.
Press

Feb 1, 2024

Insulin Prices Are Sharply Higher in the United States Than in Other Countries

The gross price of insulin in the United States is more than nine times higher than in 33 high-income comparison nations.
Press

Feb 1, 2024

New Prescription Drugs Typically Sold First in U.S., Reach Other Wealthy Nations Within a Year

Most new prescription drugs are sold first in the United States before they reach other nations, but ultimately important medications are sold across most wealthy nations within about a year of first sale.
Research

Feb 1, 2024

Comparing Insulin Prices in the United States to Other Countries: Updated Results Using 2022 Data

Using a price index approach, the authors present results from a comparison of U.S. and international insulin prices overall, for different categories of insulin, and with and without adjustments reflecting U.S. rebates from manufacturers.
Research

Feb 1, 2024

Comparing New Prescription Drug Availability and Launch Timing in the United States and Other OECD Countries

In this report, the author addresses concerns about the impact of new policies to address high U.S. prescription drug prices, comparing the availability of new drugs between the United States and other high-income countries.
Research

Feb 1, 2024

International Prescription Drug Price Comparisons: Estimates Using 2022 Data

This report summarizes findings from comparisons of drug prices in the United States and other high-income countries based on 2022 data and presents results from various sensitivity analyses.
Research

Sep 30, 2022

Environmental Scan on Consolidation Trends and Impacts in Health Care Markets

To inform the development of No Surprises Act reports to Congress, this report summarizes recent patterns of and trends in horizontal and vertical consolidation of hospitals, physician practices, and health insurers.
Research

Sep 20, 2022

Higher Medicare Spending On Imaging And Lab Services After Primary Care Physician Group Vertical Integration

This study highlights how the growing trend of vertical integration, combined with differences in Medicare payment between hospitals and nonhospital providers, leads to higher Medicare spending.

Health Care Price Competition

Health Care Price Competition

How Do U.S. Insulin Prices Compare to Those in Other Countries?

Explore RAND’s Work on this Topic

Error

Redesigning Health Care Plans to Lower Costs

Prices Paid to Hospitals by Private Health Plans: Findings from Round 5.1 of an Employer-Led Transparency Initiative

Benefits and Affordability

Private Health Plans During 2022 Paid Hospitals 254 Percent of What Medicare Would Pay

Prescription Drug Prices in the U.S. Are 2.78 Times Those in Other Countries

Insulin Prices Are Sharply Higher in the United States Than in Other Countries

New Prescription Drugs Typically Sold First in U.S., Reach Other Wealthy Nations Within a Year

Comparing Insulin Prices in the United States to Other Countries: Updated Results Using 2022 Data

Comparing New Prescription Drug Availability and Launch Timing in the United States and Other OECD Countries

International Prescription Drug Price Comparisons: Estimates Using 2022 Data

Environmental Scan on Consolidation Trends and Impacts in Health Care Markets

Higher Medicare Spending On Imaging And Lab Services After Primary Care Physician Group Vertical Integration

Oops! An unexpected error has occurred.

RAND Headquarters

Federally Funded Research Divisions

Social and Economic Policy Divisions

International

Health Care Price Competition

Health Care Price Competition

How Do U.S. Insulin Prices Compare to Those in Other Countries?

Explore RAND’s Work on this Topic

Error

Redesigning Health Care Plans to Lower Costs

Prices Paid to Hospitals by Private Health Plans: Findings from Round 5.1 of an Employer-Led Transparency Initiative

Benefits and Affordability

Private Health Plans During 2022 Paid Hospitals 254 Percent of What Medicare Would Pay

Prescription Drug Prices in the U.S. Are 2.78 Times Those in Other Countries

Insulin Prices Are Sharply Higher in the United States Than in Other Countries

New Prescription Drugs Typically Sold First in U.S., Reach Other Wealthy Nations Within a Year

Comparing Insulin Prices in the United States to Other Countries: Updated Results Using 2022 Data

Comparing New Prescription Drug Availability and Launch Timing in the United States and Other OECD Countries

International Prescription Drug Price Comparisons: Estimates Using 2022 Data

Environmental Scan on Consolidation Trends and Impacts in Health Care Markets

Higher Medicare Spending On Imaging And Lab Services After Primary Care Physician Group Vertical Integration

Oops! An unexpected error has occurred.